Cervical Cancer Diagnostics Market Size, Share, Price, Demand, Industry Analysis and Forecast 2021-2026
According to the latest report by IMARC Group, titled “Cervical Cancer Diagnostics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global cervical cancer diagnostics market size reached a strong growth in 2020. Cervical cancer diagnostics includes a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells of the human papillomavirus (HPV). They are conducted by taking a sample of the tissue obtained through punch biopsy, endocervical curettage, conization, and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, several tests, including blood, CT scan, MRI, PET scan, and visual examination of bladder and rectum, are performed to determine the disease stage.
Request Free Sample Report: https://www.imarcgroup.com/cervical-cancer-diagnostics-market/requestsample
A significant rise in the number of individuals diagnosed with sexually transmitted infections (STIs), including syphilis, chlamydia, gonorrhea, etc., is escalating the risk of HPV infection. Furthermore, with the rising awareness towards the early diagnosis and treatment of cervical cancer, several individuals are adopting HPV home testing kits that provide quick and accurate test results. Besides this, the wide availability of various treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy, and trachelectomy, is also propelling the global market for cervical cancer diagnostics. Looking forward, IMARC Group expects the global cervical cancer diagnostics market to continue its moderate growth during 2021-2026.
Breakup by Test Type:
- Pap Testing
- HPV Testing
- Cervical Biopsies
- Colposcopy
- Others
Breakup by Age Group:
- 20 to 35 years
- Above 35 years
Competitive Landscape with Key Player:
- Abbott Laboratories
- Arbor Vita Corporation
- Becton
- Dickinson and Company
- Cooper Surgical Inc.
- F. Hoffmann-La Roche AG
- Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/cervical-cancer-diagnostics-market